Picture of Covista logo

CVSA — Covista News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesAdventurousLarge CapSuper Stock

Covista Q4 revenue beats analyst estimates on record enrollment levels

Covista Q4 revenue beats analyst estimates on record enrollment levels


Overview

  • US healthcare educator's Q4 revenue rose 9.7%, beating analyst expectations

  • Adjusted EPS for Q4 beat consensus, rising 25.9% year-over-year

  • Company repurchased $238 mln of shares in fiscal year 2026


Outlook

  • Covista sees fiscal 2027 revenue between $2.05 bln and $2.09 bln, up 5%-7% YoY

  • Company expects fiscal 2027 adjusted EPS of $8.90-$9.15, up 8%-11% YoY

  • Covista says it enters fiscal 2027 with momentum and is tracking ahead of long-term targets


Result Drivers

  • WALDEN ENROLLMENT GROWTH - Walden University enrollment rose 14% year-over-year, driving a 15.7% increase in Q4 revenue and contributing to record enrollment levels

  • CHAMBERLAIN NURSING DEMAND - Chamberlain University enrollment grew 1.6% in Q4, supported by pre-licensure nursing and new employer collaborations

  • MEDICAL AND VETERINARY GROWTH - Medical and Veterinary segment enrollment increased 7.3% year-over-year, supporting an 10.7% rise in Q4 revenue


Company press release: ID:nBwc0Qqma


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$501.40 mln

$486.63 mln (4 Analysts)

Q4 Adjusted EPS

Beat

$2.09

$1.89 (4 Analysts)

Q4 EPS

$2.06

Q4 Adjusted Net Income

Beat

$72.80 mln

$65.29 mln (4 Analysts)

Q4 Net Income

$71.70 mln

Q4 Adjusted EBITDA

Beat

$126.90 mln

$123.64 mln (3 Analysts)

Q4 Adjusted Operating Income

Beat

$100.90 mln

$98.95 mln (4 Analysts)

Q4 Adjusted EBITDA Margin

25.30%

Q4 Operating Income

$95.40 mln


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the miscellaneous educational service providers peer group is "buy."

  • Wall Street's median 12-month price target for Covista Inc. is $155.00, about 20.2% above its August 5 closing price of $128.91

  • The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 13 three months ago


Reuters Recommended Reads

  • Aug 4 - Stride Q4 revenue, adjusted EPS beats estimates

  • Aug 5 - Universal Technical Q3 adjusted EPS down; co lowers FY guidance

  • Aug 5 - Duolingo's soft quarterly revenue outlook overshadows stronger user growth forecast


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Covista

See all news